Health of Population of Lithuania (edition 2020)
Preventive practices
Nuotr. iš Pixabay.com
Preventive practices
Disease prevention programmes help to diagnose and effectively treat some diseases at an early stage.
Prevention of arterial hypertension
High arterial blood pressure (arterial hypertension) is one of the major risk factors for cardiovascular disease. According to the WHO data, 1.13 billion people worldwide have arterial hypertension. Experience in many countries shows that with the improvement in arterial blood pressure control, there is a decrease in population morbidity and mortality from stroke, myocardial infarction and other cardiovascular diseases.
The survey results showed that in the period of 12 months before the survey, 69 per cent of population aged 25 and older (women – 76 per cent, men – 61 per cent) had arterial blood pressure measured by medical professional.
The lowest proportion of men and women who had blood pressure measured by a medical professional was in the 25–44 age group (women – 60 per cent, men – 45 per cent).
Population aged 25 and older who had arterial blood pressure measured in the last 12 months by a medical professional, by age group, 2014 and 2019
Per cent
The latest and detailed data are available in the Database of Indicators.
Population aged 25 and older who had arterial blood pressure measured in the last 12 months by a medical professional, by age group and sex, 2014 and 2019
Per cent
2014 | 2019 |
|
|
The latest and detailed data are available in the Database of Indicators.
Test of blood cholesterol level
An increase in blood cholesterol is one of the major risk factors for cardiovascular disease.
The results show that in the year before the survey 62 per cent of women (in 2014, 56 per cent) and 50 per cent of men (in 2014, 43 per cent) had their blood cholesterol levels measured.
Persons who had their blood cholesterol levels measured in the last 12 months, by age group, 2014 and 2019
Per cent
The latest and detailed data are available in the Database of Indicators.
Persons who had their blood cholesterol levels measured in the last 12 months, by age group and sex, 2014 and 2019
Per cent
2014 | 2019 |
|
|
The latest and detailed data are available in the Database of Indicators.
Test of blood sugar level
63 per cent of women (in 2014, 58 per cent) and 50 per cent of men (in 2014, 45 per cent) had their blood sugar level tested.
Persons who had their blood sugar levels measured in the last 12 months, by age group, 2014 and 2019
Per cent
The latest and detailed data are available in the Database of Indicators.
Persons who had their blood sugar levels measured in the last 12 months, by age group and sex, 2014 and 2019
Per cent
2014 | 2019 |
|
|
The latest and detailed data are available in the Database of Indicators.
Mammography test
Mammography tests allow timely diagnosis of benign and malignant changes in breast tissue and timely initiation of appropriate treatment. The mammography screening programs are suggested for women aged 50–69, every two years. 88 per cent of women aged 50–69 (in 2014, 80 per cent) had mammography test at least once in their lives, within 2 years before the survey – 53 per cent (in 2014, 47 per cent), 2 or more years ago – 35 per cent (in 2014, 33 per cent).
Women aged 50–69 by time of mammography test, 2014 and 2019
2014 | 2019 |
|
|
The latest and detailed data are available in the Database of Indicators.
Women by time of mammography test and age group, 2014 and 2019
Per cent
The latest and detailed data are available in the Database of Indicators.
Cervical smear test
As part of a cervical cancer prevention programme, women aged 25–60 undergo a cytological smear test every 3 years, which helps to detect precancerous cell changes.
In the Health Interview Survey, 91 per cent of women aged 25–60 (in 2014, 87 per cent) indicated that they have had cervical cytology test (PAP test) at least once in their lifetime. Within a year before the survey, 28 per cent of women (in 2014, 25 per cent) had PAP test, within 1–3 years – 47 per cent (in 2014, 45 per cent). Compared to 2014, the proportion of women who had PAP test 3 and more years ago remained unchanged (17 per cent).
Women aged 25–60 by time of cervical cytology test, 2014 and 2019
Per cent
2014 | 2019 |
|
|
The latest and detailed data are available in the Database of Indicators.
Women by time of cervical cytology test and age group, 2014 and 2019
Per cent
The latest and detailed data are available in the Database of Indicators.